AbbVie Inc

AbbVie Inc. is one of the world’s largest biopharmaceutical companies, focused on discovering, developing, manufacturing, and commercialising medicines for serious and complex diseases. The company operates across major therapeutic areas including immunology, oncology, neuroscience, eye care, aesthetics, and specialty medicine, with products used by patients and healthcare systems across global markets.

AbbVie’s strength comes from its research capability, global commercial scale, strong specialist medicine portfolio, and leadership in areas such as immunology and neuroscience. While the company has had to manage the loss of exclusivity for Humira, it has been building its next phase of growth through medicines such as Skyrizi and Rinvoq, alongside its oncology, aesthetics, eye care, and neuroscience franchises. This gives AbbVie a defensive healthcare profile with long-term exposure to innovation in chronic disease, specialty medicine, and advanced therapies.